30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Ellen Zane

Insider profile

Currently holds positions in PAREXEL International Corp, Azenta Inc, Boston Scientific Corp and Haemonetics Corp

Positions

Position Company Period
Independent Director PAREXEL International Corp July 26, 2006 -
Independent Director Azenta Inc May 9, 2012 -
Independent Director Boston Scientific Corp April 15, 2016 -
Independent Director Haemonetics Corp Jan. 1, 2018 -
Independent Director Haemonetics Corp July 27, 2012 - April 10, 2016
Independent Director Lincare Holdings Inc Sept. 16, 2010 - Aug. 8, 2012

Ellen Zane's trades of Boston Scientific Corp's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-11-06 2025-11-06 PrS Proposed sale
13,510
396.46
US$4,946,429
13,510 396.46 US$4,946,429
2025-11-06 2025-11-06 PlS Planned sale
68,265 -49.2%
285.86
US$3,621,137
68,265 -49.2% 285.86 US$3,621,137
2025-10-28 2025-10-28 PrS Proposed sale
2,330
333.86
US$4,263,508
2,330 333.86 US$4,263,508
2025-10-28 2025-10-28 PlS Planned sale
2,901 -10.7%
102.24
US$296,599
2,901 -10.7% 102.24 US$296,599
2025-10-28 2025-10-27 PlS Planned sale
9,990 -27.0%
101.13
US$1,010,301
9,990 -27.0% 101.13 US$1,010,301
2025-10-27 2025-10-27 PrS Proposed sale
9,990
100.91
US$1,008,081
9,990 100.91 US$1,008,081
2025-02-24 2025-02-24 PrS Proposed sale
13,586
104.23
US$1,416,088
13,586 104.23 US$1,416,088
2025-02-24 2025-02-24 PlS Planned sale
13,586 -28.0%
104.23
US$1,416,134
13,586 -28.0% 104.23 US$1,416,134
2023-08-09 2023-08-09 PrS Proposed sale
18,766
55.78
US$1,046,697
18,766 55.78 US$1,046,697